News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,820 Results
Type
Article (1133)
Press Release (55687)
Section
Business (15654)
Career Advice (85)
Deals (2457)
Drug Delivery (1)
Drug Development (13976)
Employer Resources (4)
FDA (2428)
Job Trends (1922)
News (33197)
Policy (2314)
Tag
Academia (156)
Accelerated approval (2)
Adcomms (1)
Allergies (24)
Alliances (1931)
ALS (17)
Alzheimer's disease (200)
Antibody-drug conjugate (ADC) (14)
Approvals (2490)
Artificial intelligence (51)
Autoimmune disease (9)
Automation (1)
Bankruptcy (4)
Best Places to Work (2046)
Biosimilars (9)
Biotechnology (1)
Bladder cancer (34)
Brain cancer (3)
Breast cancer (104)
Cancer (646)
Cardiovascular disease (42)
Career advice (78)
Career pathing (1)
CAR-T (19)
Cell therapy (64)
Cervical cancer (5)
Clinical research (13152)
Collaboration (152)
Compensation (38)
Complete response letters (1)
COVID-19 (211)
CRISPR (4)
C-suite (29)
Cystic fibrosis (15)
Data (761)
Depression (6)
Diabetes (59)
Diagnostics (494)
Digital health (6)
Diversity, equity & inclusion (2)
Drug discovery (20)
Drug pricing (3)
Drug shortages (2)
Duchenne muscular dystrophy (16)
Earnings (12925)
Editorial (3)
Employer branding (2)
Employer resources (4)
Events (7921)
Executive appointments (143)
FDA (2785)
Fibrodysplasia Ossificans Progressiva (1)
Funding (128)
Gene editing (7)
Generative AI (1)
Gene therapy (37)
GLP-1 (67)
Government (233)
Grass and pollen (2)
Guidances (15)
Healthcare (1503)
Huntington's disease (2)
IgA nephropathy (5)
Immunology and inflammation (12)
Indications (10)
Infectious disease (230)
Inflammatory bowel disease (15)
Influenza (8)
Intellectual property (9)
Interviews (13)
IPO (1743)
IRA (1)
Job creations (108)
Job search strategy (74)
Kidney cancer (4)
Labor market (1)
Layoffs (12)
Legal (133)
Liver cancer (14)
Lung cancer (125)
Lymphoma (57)
Machine learning (1)
Manufacturing (21)
MASH (20)
Medical device (1294)
Medtech (1294)
Mergers & acquisitions (831)
Metabolic disorders (127)
Multiple sclerosis (27)
NASH (4)
Neurodegenerative disease (14)
Neuroscience (313)
NextGen: Class of 2025 (330)
Non-profit (227)
Northern California (552)
Obesity (50)
Opinion (3)
Ovarian cancer (21)
Pain (15)
Pancreatic cancer (20)
Parkinson's disease (37)
Partnered (1)
Patents (22)
Patient recruitment (24)
Peanut (15)
People (1627)
Pharmaceutical (2)
Phase I (2876)
Phase II (5039)
Phase III (5964)
Pipeline (393)
Policy (1)
Postmarket research (612)
Preclinical (574)
Prostate cancer (33)
Psychedelics (1)
Radiopharmaceuticals (34)
Rare diseases (58)
Real estate (95)
Recruiting (1)
Regulatory (2329)
Reports (7)
Research institute (160)
Resumes & cover letters (8)
Rett syndrome (2)
RSV (9)
Schizophrenia (24)
Series A (19)
Series B (13)
Sickle cell disease (6)
Southern California (427)
Special edition (1)
Spinal muscular atrophy (21)
Sponsored (1)
Startups (110)
Stomach cancer (1)
Supply chain (15)
United States (4527)
Vaccines (79)
Venture capitalists (2)
Weight loss (6)
Women's health (3)
Date
Today (33)
Last 7 days (96)
Last 30 days (628)
Last 365 days (6936)
2025 (2227)
2024 (6089)
2023 (5248)
2022 (6229)
2021 (6259)
2020 (5060)
2019 (4015)
2018 (2941)
2017 (2864)
2016 (2287)
2015 (2679)
2014 (1742)
2013 (1125)
2012 (1218)
2011 (1284)
2010 (1057)
Location
Africa (45)
Alabama (2)
Alaska (1)
Arizona (11)
Arkansas (2)
Asia (4499)
Australia (416)
California (1210)
Canada (326)
China (136)
Colorado (61)
Connecticut (89)
Delaware (81)
Europe (8518)
Florida (142)
Georgia (38)
Idaho (2)
Illinois (131)
India (4)
Indiana (68)
Iowa (2)
Japan (77)
Kansas (16)
Maine (9)
Maryland (154)
Massachusetts (868)
Michigan (30)
Minnesota (59)
Missouri (18)
Montana (4)
Nebraska (3)
Nevada (11)
New Hampshire (13)
New Jersey (534)
New Mexico (3)
New York (358)
North Carolina (144)
Northern California (552)
Ohio (39)
Oregon (7)
Pennsylvania (217)
Puerto Rico (1)
Rhode Island (3)
South America (63)
South Carolina (3)
Southern California (427)
Tennessee (25)
Texas (179)
Utah (23)
Virginia (28)
Washington D.C. (13)
Washington State (82)
West Virginia (1)
Wisconsin (25)
56,820 Results for "3d4medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope
Synaptive Medical Inc. has received 510(k) clearance from the Food and Drug Administration (FDA) for its Near-Infrared fluorescence visualization module, Modus IR, adding to the existing fluorescence offering on its 4K 3D robotic exoscope, Modus X.
March 27, 2024
·
2 min read
Bio NC
Dentsply Sirona announces latest steps to further drive its leadership in digital dentistry, including an exciting collaboration with Google Cloud and the launch of a medical-grade 3D printing solution. Virtual event to be held March 4.
Dentsply Sirona will introduce a series of innovations designed to significantly enhance digital workflows with benefits for dentists, dental labs and patients globally.
February 25, 2022
·
5 min read
Press Releases
Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance
April 16, 2025
·
17 min read
Silence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines Conference
Silence Therapeutics plc announced that Giles Campion, MD, Head of R&D and Chief Medical Officer, will participate in a fireside chat at the Chardan Genetic Medicines Conference on Tuesday, October 4th at 3:45 p.m. ET in New York.
September 27, 2022
·
1 min read
Biotech Bay
Adverum Biotechnologies to Participate in the Chardan 6th Annual Genetic Medicines Conference
Adverum Biotechnologies, Inc. today announced that Richard Beckman, M.D., chief medical officer of Adverum Biotechnologies, will participate in a fireside chat at Chardan’s 6th Annual Genetic Medicines Conference on October 3, 2022, at 4:00 p.m. ET.
September 27, 2022
·
1 min read
Press Releases
Topline Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in Patients with Early Alzheimer’s Disease Carrying Two Copies of APOE4 Gene
April 10, 2025
·
13 min read
Press Releases
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)
April 15, 2025
·
9 min read
Press Releases
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1
April 8, 2025
·
19 min read
Press Releases
Sarepta Therapeutics Announces Pipeline Progress for Multiple Limb-Girdle Muscular Dystrophy Programs
April 15, 2025
·
8 min read
Press Releases
Dermata’s XYNGARI(TM) Phase 3 Trial Hits Statistically Significant Difference at 4 Weeks
April 16, 2025
·
6 min read
1 of 5,682
Next
